Literature DB >> 28498460

MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway.

Yun-Tan Qiu1, Wen-Jun Wang1, Bing Zhang1, Li-Li Mei1, Zhi-Zhou Shi1.   

Abstract

The roles and mechanisms of mini-chromosome maintenance complex component 7 (MCM7) amplification and overexpression in esophageal carcinogenesis were investigated. By analyzing the TCGA datasets, we found that MCM7 was amplified in approximately 12% of esophageal squamous cell carcinomas (ESCCs), and in more than 4% of head and neck squamous cell carcinomas and stomach carcinomas. Overexpression of MCM7 was further verified in three independent GEO datasets of esophageal cancer. Knockdown of MCM7 using two siRNAs significantly inhibited cell proliferation, colony formation and migration of KYSE510 and EC9706 cells in vitro. Noteworthy, we further found that silencing of MCM7 suppressed the phosphorylation of AKT1 and mTOR both in KYSE510 and EC9706 cells, and reduced the cell cycle regulatory proteins cyclin D1, cyclin E2 and CDK2. Taken together, our findings suggested that MCM7 promoted tumor cell proliferation, colony formation and migration of ESCC cells via activating AKT1/mTOR signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28498460     DOI: 10.3892/or.2017.5614

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

1.  Multi-omics-based identification of atopic dermatitis target genes and their potential associations with metabolites and miRNAs.

Authors:  Animesh Acharjee; Elizaveta Gribaleva; Subia Bano; Georgios V Gkoutos
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  ITRAQ-based quantitative proteomic analysis reveals that VPS35 promotes the expression of MCM2-7 genes in HeLa cells.

Authors:  Xian Hong; Tao Wang; Juan Du; Yu Hong; Cai-Ping Yang; Wei Xiao; Yang Li; Ming Wang; He Sun; Zhi-Hui Deng
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

3.  MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer.

Authors:  Zhenzhen Wu; Yueyuan Wang; Juan Li; Huiling Wang; Xunyuan Tuo; Jing Zheng
Journal:  Front Genet       Date:  2022-05-19       Impact factor: 4.772

4.  Ablation of MCM10 using CRISPR/Cas9 restrains the growth and migration of esophageal squamous cell carcinoma cells through inhibition of Akt signaling.

Authors:  Jie Yan; Pan Du; Yongxu Jia; Zhiwei Chang; Silin Gan; Xiaohan Xu; Yaohe Wang; Yanru Qin; Quancheng Kan
Journal:  Onco Targets Ther       Date:  2018-06-06       Impact factor: 4.147

5.  Identification of key genes and pathways for esophageal squamous cell carcinoma by bioinformatics analysis.

Authors:  Xiaohua Chen; Sina Cai; Baoxia Li; Xiaona Zhang; Wenhui Li; Henglun Linag; Xiaolong Cao
Journal:  Exp Ther Med       Date:  2018-06-15       Impact factor: 2.447

6.  A DNA replication-independent function of pre-replication complex genes during cell invasion in C. elegans.

Authors:  Evelyn Lattmann; Ting Deng; Michael Walser; Patrizia Widmer; Charlotte Rexha-Lambert; Vibhu Prasad; Ossia Eichhoff; Michael Daube; Reinhard Dummer; Mitchell P Levesque; Alex Hajnal
Journal:  PLoS Biol       Date:  2022-02-22       Impact factor: 8.029

7.  NOL6 Regulates the Proliferation and Apoptosis of Gastric Cancer Cells via Regulating TP53I3, CDK4 and MCM7 Expression.

Authors:  Lei He; Xiaohan Qian; Pingping Ge; Dong Fan; Xiang Ma; Qiong Wu; Jin Sun; Lihua Yang; Jian Shen; Lijian Xu
Journal:  Front Oncol       Date:  2022-04-12       Impact factor: 5.738

8.  Expression of Minichromosome Maintenance Proteins (MCM) and Cancer Prognosis: A meta-analysis.

Authors:  Kaihua Gou; Jingwei Liu; Xue Feng; Hao Li; Yuan Yuan; Chengzhong Xing
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207

Review 9.  MCMs in Cancer: Prognostic Potential and Mechanisms.

Authors:  Si Yu; Guanqun Wang; Yue Shi; Haifeng Xu; Yongchang Zheng; Yang Chen
Journal:  Anal Cell Pathol (Amst)       Date:  2020-02-03       Impact factor: 2.916

10.  A comprehensive exploration of pharmacological properties, bioactivities and inhibitory potentiality of luteolin from Tridax procumbens as anticancer drug by in-silico approach.

Authors:  Shradha Lakhera; Meenakshi Rana; Kamal Devlal; Ismail Celik; Rohitash Yadav
Journal:  Struct Chem       Date:  2022-01-28       Impact factor: 1.795

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.